antibody-drug conjugate

FDA pauses Mersana’s clinical trial after patient dies
FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
Flag link:
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Vertex Pharmaceuticals
Immunogen
gen editing
antibody-drug conjugate
exa-cel
Flag link:
AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
Medical Marketing and Media
AstraZeneca
CMG901
antibody-drug conjugate
gastric cancer
KYM Biosciences
Flag link:
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
Flag link:
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
Fierce Pharma
Abzena
CDMOs
layoffs
antibody-drug conjugate
Flag link:
Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial
Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial
Endpoints
Sutro BioPharma
clinical trials
antibody-drug conjugate
ovarian cancer
luveltamab tazevibulin
Flag link:
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Amgen
antibody-drug conjugate
Synaffix
Flag link:
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
antibody-drug conjugate
Merck
LegoChem Biosciences
Mersana
Amgen
GSK
Janssen
Flag link:
Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal
Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal
BioSpace
Merck
China
Kelun-Biotech
antibody-drug conjugate
oncology
Flag link:
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
Flag link:
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent
BioSpace
Exelixis
Catalent
antibody-drug conjugate
Flag link:
Mablink Breaks into ADC Space with $30M for Improved Linker Tech
Mablink Breaks into ADC Space with $30M for Improved Linker Tech
BioSpace
Mablink
antibody-drug conjugate
MBK-103
cancer
Flag link:
Synaffix rustles up another ADC deal, allying with Emergence in $360M biobuck pact
Synaffix rustles up another ADC deal, allying with Emergence in $360M biobuck pact
Fierce Biotech
Synaffix
Emergence Therapeutics
antibody-drug conjugate
Flag link:
Uncertainty at Ambrx as biotech loses CEO, takes hard look at pipeline
Uncertainty at Ambrx as biotech loses CEO, takes hard look at pipeline
Fierce Biotech
Ambrx
Bristol Myers Squibb
antibody-drug conjugate
Flag link:
GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep
GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep
Fierce Biotech
GSK
Mersana
antibody-drug conjugate
Blenrep
XMT-2056
Flag link:
Merck picks up another ADC agreement
Merck picks up another ADC agreement
Biopharma Reporter
Merck
antibody-drug conjugate
Sichuan Kelun Pharmaceutical
Flag link:
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Endpoints
Elevation Oncology
gastric cancer
pancreatic cancer
antibody-drug conjugate
Flag link:
Merck's ADC hunt continues with second deal for China biotech Kelun
Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Merck
antibody-drug conjugate
solid tumors
China
Kelun Biotech
Flag link:
Astellas pumps $90m into Sutro immuno-oncology alliance
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Astellas
Sutro BioPharma
antibody-drug conjugate
cancer
immuno-oncology
Flag link:
US: Merck doubles production capacity of ADC components
US: Merck doubles production capacity of ADC components
Biopharma Reporter
Merck
antibody-drug conjugate
drug manufacturing
Flag link:

Pages